In This Section:

◄
Clinical publications
Editorials
Radcliffe Content
Review Articles
►

Cardiomyopathy

Welcome to our featured section on cardiomyopathy

Click here to take the CME-accredited courses. 

This educational hub pulls together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub will be CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos. 

 

See more ▼
Close X
Other videos you might like

Section Advisor

Professor Perry Elliott

Chair, Cardiovascular Medicine, University College London, and Head, Clinical Research, UCL Institute of Cardiovascular Science, London, UK

Supported through an educational grant from Bristol Myers Squibb.

Clara Saldarriaga, Gianluigi Savarese, Javed Butler, et al

Clara Saldarriaga, Gianluigi Savarese, Javed Butler, et al

AHA 23: Screening for Peripartum Cardiomyopathies Using an AI Enanced Digital Stethoscope

Video

AHA 23: AI Screening for Peripartum Cardiomyopathies

Demilade Adedinsewo,

Watch time: 4m 59s

Video Series

e-SPACE Heart Failure 2023

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)

Broadcast

Updates in HCM Management: ESC Cardiomyopathy Guidelines 2023

Elena Arbelo, Juan-Pablo Kaski,

Watch time: 59m 7s
Conversations about HCM: Symptoms, Diagnosis and Management

Video

Conversations about HCM: Symptoms, Diagnosis and Management

Ankur Kalra, Carolyn Ho,

Watch time: 51m 52s
HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in symptomatic nHCM

Video

HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in symptomatic nHCM

Ahmad Masri,

Watch time: 6m 54s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Video

HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall,

Watch time: 5m 48s

William T Abraham, Marianna Adamo, Stefan Anker, et al

William T Abraham, Marianna Adamo, Stefan Anker, et al

Video Series

e-SPACE Cardio-Renal-Metabolic 2023

Fausto J Pinto, Kerri L Cavanaugh, John Spertus, et al

Matthew E Li Kam Wa , Saba Z Assar , Ajay J Kirtane , et al

Read time: 18m

Alexander G Truesdell , Rhian E Davies , Moemen Eltelbany , et al

Read time: 18 Mins

Essa Hariri , Anna Scandinaro , Mazen M Al Hammoud , et al

Recent Videos

AHA 24: Nexiguran Ziclumeran for ATTR-CM

Video

AHA 24: Nexiguran Ziclumeran for ATTR-CM

Marianna Fontana,

Watch time: 5m 6s
AHA 24: The REMS Program for Mavacamten

Video

AHA 24: The REMS Program for Mavacamten

Milind Y Desai,

Watch time: 7m 19s
AHA 24: The VALOR-HCM Trial

Video

AHA 24: The VALOR-HCM Trial

Milind Y Desai,

Watch time: 10m 31s

Video Series

e-SPACE Heart Failure 2024

Maria Rosa Costanzo, JoAnn Lindenfeld, Nicolas Girerd, et al

Clara Saldarriaga, Gianluigi Savarese, Javed Butler, et al

Clara Saldarriaga, Gianluigi Savarese, Javed Butler, et al

Clinical publications

Entropy of left ventricular late gadolinium enhancement and its prognostic value in hypertrophic cardiomyopathy a new CMR assessment method

Zhao X, Jin F, Wang J, et al. Int J Cardiol 2023;373:134–41.

Efficacy of SGLT2 inhibitors in patients with diabetes and nonobstructive hypertrophic cardiomyopathy

Subramanian M, Sravani V, Krishna SP, et al. Am J Cardiol 2023;188:80–6.

Implications of structural right ventricular involvement in patients with hypertrophic cardiomyopathy

Zhang Y, Zhu Y, Zhang M, et al. Eur Heart J Qual Care Clin Outcomes 2023;9:34–41.

Impact of hospital volume on outcomes of septal myectomy for hypertrophic cardiomyopathy

Holst KA, Schaff HV, Smedira NG, et al. Ann Thorac Surg 2022;114:2131–8.

Detecting regional fibrosis in hypertrophic cardiomyopathy: the utility of myocardial strain based on cardiac magnetic resonance

She J, Zhao S, Chen Y, et al. Acad Radiol 2023;30:230–8.

Clinical features of heart failure in patients with hypertrophic cardiomyopathy in a regional Japanese cohort　― results from the Kochi RYOMA study ―

Miyamoto Y, Kubo T, Ochi Y, et al. Circ J 2022;86:1934–40.

Impact of race and ethnicity on use and outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy

Patlolla SH, Schaff HV, Nishimura RA, et al. J Am Heart Assoc 2023;12:e026661.

Automated quantification of abnormal QRS peaks from high‐resolution ECGs predicts late ventricular arrhythmias in hypertrophic cardiomyopathy: a 5‐year prospective multicenter study

Suszko AM, Chakraborty P, Viswanathan K, et al. J Am Heart Assoc 2022;11:e026025.

Identification of transthyretin cardiac amyloidosis among patients previously diagnosed with hypertrophic cardiomyopathy

Rowin EJ, Ruberg FL, Das G, et al. Circ Cardiovasc Imaging 2022;15:e014938.

Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy?

Lentz Carvalho J, Schaff HV, Nishimura RA, et al. J Thorac Cardiovasc Surg 2023;165:79–87.e1.

Using electronic health record data to improve understanding of the risk of mental disorders in patients diagnosed with hypertrophic cardiomyopathy

Jin K. Eur J Prev Cardiol 2023;30:82–4.

Risk of incident mental disorders in hypertrophic cardiomyopathy: a nationwide propensity-matched study

Park JB, Yun JY, Kim B, et al. Eur J Prev Cardiol 2023;30:85–94.

Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy

Wheeler MT, Jacoby D, Elliott PM, et al. Eur J Heart Fail 2022; epub ahead of press.

Survival after septal reduction in patients >65 years old with obstructive hypertrophic cardiomyopathy

Mentias A, Smedira NG, Krishnaswamy A, et al. J Am Coll Cardiol 2023;81:105–15.

Phase 2 study of aficamten in patients with obstructive hypertrophic cardiomyopathy

Maron MS, Masri A, Choudhury L, et al. J Am Coll Cardiol 2023;81:34–45.

Editorials

Syncope in hypertrophic cardiomyopathy: explaining the unexplained

Geske JB, Siontis KC, Gersh BJ. Int J Cardiol 2023;373:99–100.

High‐resolution ECG for predicting ventricular arrhythmia in hypertrophic cardiomyopathy: another tool in the toolbox

Gehi AK. J Am Heart Assoc 2022;11:e028095.

Composite endpoints in hypertrophic cardiomyopathy: practice, education, research

Ommen SR. JACC Heart Fail 2023;11:42–3.

Mavacamten in obstructive hypertrophic cardiomyopathy – are beta-blockers blocking part of its shine?

Dominguez F, Cabrera E. Eur J Heart Fail 2023; epub ahead of press.

Increased long-term survival after myectomy: is the pendulum swinging again in this 30-year debate?

Maron MS. J Am Coll Cardiol 2023;81:116–8.

Myosin inhibitors: the next generation

Nair A, Xie L, Silva Enciso JE. J Am Coll Cardiol 2023;81:46–8.

Radcliffe Content

Electrocardiographic Findings in Patients with Severe COVID-19: Characterisation and Clinical Correlations

Journal of Asian Pacific Society of Cardiology 2024;3:e38.

Hypertrophic Cardiomyopathy as a Form of Heart Failure with Preserved Ejection Fraction: Diagnosis, Drugs, and Procedures

US Cardiology Review 2024;18:e17.

Imaging Advances in Heart Failure

Cardiac Failure Review 2024;10:e12.

Apical Hypertrophic Cardiomyopathy in Middle-aged Male with Chest Pain

US Cardiology Review 2024;18:e15.

Management of Post-cardiotomy Shock

US Cardiology Review 2024;18:e11.

Executive Summary from the 2023 Charleston HFpEF Conference

US Cardiology Review 2024;18:e07.

The Unwanted Soft Spot: A Rare Case of Biventricular Non-compaction Cardiomyopathy Causing Heart Failure in an Adult Filipino Male

Journal of Asian Pacific Society of Cardiology 2024;3:e18.

Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review

Cardiac Failure Review 2024;10:e06.

Coronary Revascularisation in Heart Failure with Reduced Ejection Fraction

Journal of Asian Pacific Society of Cardiology 2024;3:e14

Cardiac Amyloidosis: Everywhere, but Nowhere

Journal of Asian Pacific Society of Cardiology 2024;3:e05

In Cardiogenic Shock, Age is Not Just a Number

Cardiac Failure Review 2024;10:e04.

Red Flags in Acute Myocarditis

Cardiac Failure Review 2024;10:e02.

Multisystem Inflammatory Syndrome in an Adult: A Rare Cause of ST-Segment Elevation MI

Journal of Asian Pacific Society of Cardiology 2023;2:e44.

Explaining the Unexplained: A Practical Approach to Investigating the Cardiac Arrest Survivor

Arrhythmia & Electrophysiology Review 2023;12:e27

Risk Factors for Aortic Dissection

US Cardiology Review 2023;17:e17.

Cardiovascular Involvement in Fabry’s Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management

Cardiac Failure Review 2023;9:e12.

Contemporary Review of the Management of Left Ventricular Thrombus

Journal of Asian Pacific Society of Cardiology 2023;2:e23.

How Can We Survive the Heart Failure Pandemic Era? Basic Research for Understanding the Pathophysiology of Heart Failure and Development of Novel Therapies

Journal of Asian Pacific Society of Cardiology 2023;2:e15.

Role of Imaging in Cardiomyopathies

Cardiac Failure Review 2023;9:e08.

Review Articles

Role of cardiac magnetic resonance (CMR) in planning ventricular septal myomectomy in patients with hypertrophic obstructive cardiomyopathy (HOCM)

Alenezi F, Alajmi H, Agarwal R, Zwischenberger BA. J Card Surg 2022;37:4186–9.

The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy—a systematic review and meta-analysis

Cirino AL, Harris SL, Murad AM, et al. J Genet Couns 2022;31:1290–305.

Systematic review and meta-analysis of cardiovascular consequences of myocardial bridging in hypertrophic cardiomyopathy

Bruce C, Ubhi N, McKeegan P, Sanders K. Am J Cardiol 2023;188:110–9.

Mavacamten: a novel disease-specific treatment for hypertrophic cardiomyopathy

Capilupi MJ, Frishman WH. Cardiol Rev 2023;31:45–51.

One gene, two modes of inheritance, four diseases: a systematic review of the cardiac manifestation of pathogenic variants in JPH2-encoded junctophilin-2

Parker LE, Kramer RJ, Kaplan S, Landstrom AP. Trends Cardiovasc Med 2023;33:1–10.

Comparison of demographic, clinical, biochemical, and imaging findings in hypertrophic cardiomyopathy prognosis: a network meta-analysis

Georgiopoulos G, Figliozzi S, Pateras K, et al. JACC Heart Fail 2023;11:30–41.